| 序号 |
标题 |
次数 |
作者 |
发布时间 |
| 92476 |
DOTA-MSH ；大环配体-MSH多肽 |
135 |
wyh |
2024-11-22 |
| 92477 |
WSCS-DOTA-BBN功能化的AuNPs WSCS-DOTA-BBN-AuNPs |
168 |
zcy |
2024-11-22 |
| 92478 |
3-碘-2-丙炔基-丁基氨基甲酸酯 |
150 |
WYQ |
2024-11-22 |
| 92479 |
CAS号：272120-41-9，DOTA tribenzyl ester |
117 |
kx |
2024-11-22 |
| 92480 |
DOTA缀合肽M2pep DOTA-M2pep |
252 |
zcy |
2024-11-22 |
| 92481 |
CAS号：173308-19-5，DOTAMA(t-BuO)3-en |
121 |
kx |
2024-11-22 |
| 92482 |
3-(3,3,3-三氟-1-丙炔基)-2,2-二甲基环丙烷羧酸酯 |
135 |
WYQ |
2024-11-22 |
| 92483 |
DOTA-tris(TBE)-amido dPEG-MAL |
143 |
zyl |
2024-11-22 |
| 92484 |
1,4,7,10-四氮杂环十二烷-1,4,7,10-四乙酸 1-(2,5-二氧代-1-吡咯烷基)酯 |
144 |
kx |
2024-11-22 |
| 92485 |
DOTA-PEG-biotin DOTA-聚乙二醇-生物素 |
122 |
zcy |
2024-11-22 |
| 92486 |
DOTA-PEG(23)-bromoacetamide*2TFA |
136 |
zyl |
2024-11-22 |
| 92487 |
CAS号：219143-29-0，DOTA-(MeAm)4 |
138 |
kx |
2024-11-22 |
| 92488 |
DOTA(tBu3)-PEG(4)-TFP |
133 |
zyl |
2024-11-22 |
| 92489 |
DOTA-MBP 齐岳定制 |
147 |
zcy |
2024-11-22 |
| 92490 |
CAS号：293295-66-6，Y-DOTA-TOC |
114 |
kx |
2024-11-22 |
| 92491 |
CAS：2792156-83-1 IPB-K(DOTA)-FAPI |
122 |
zyl |
2024-11-22 |
| 92492 |
1，4，7，10-四氮杂环十二烷-1，4，7，10-四乙酸-Ser-Ser-Ser-LTVSPWY |
136 |
zcy |
2024-11-22 |
| 92493 |
CAS号：474424-15-2，dota-pnp |
136 |
kx |
2024-11-22 |
| 92494 |
CU-64 DOTA-TATE |
145 |
zyl |
2024-11-22 |
| 92495 |
DOTA-hLL2 螯合剂DOTA偶联人源化抗体hLL2 |
151 |
zcy |
2024-11-22 |
| 92496 |
DOTA-PSMA-EB-01 |
137 |
zyl |
2024-11-22 |
| 92497 |
1610950-41-8,DOTA-MeTz,DOTA-甲基四嗪 |
134 |
kx |
2024-11-22 |
| 92498 |
p-NCS-benzyl-DOTA p-NCS-苄基-DOTA |
193 |
zcy |
2024-11-22 |
| 92499 |
1189194-64-6,DOTA-(COOt-Bu)3-CH2-Alkynyl |
117 |
kx |
2024-11-22 |
| 92500 |
DOTA-cyclo(RGDfK)；DOTA-RGD |
131 |
wyh |
2024-11-22 |
| 92501 |
CuAAC修饰的DOTAZA 齐岳定制 |
164 |
zcy |
2024-11-22 |
| 92502 |
1039726-31-2，DOTA-JR-11 |
122 |
kx |
2024-11-22 |
| 92503 |
zher2-HSA-DOTA DOTA螯合剂偶联ZHER2支架多肽缀合人血清白蛋白 |
186 |
zcy |
2024-11-22 |
| 92504 |
CAS：1800229-46-2 Maleimide-DOTA-GA |
151 |
zyl |
2024-11-22 |
| 92505 |
panitumumab-DOTA DOTA标记的抗EGFR帕尼单抗 |
143 |
zcy |
2024-11-22 |
| 92506 |
DOTA-CH2-Ph-azide(HCl salt) |
136 |
kx |
2024-11-22 |
| 92507 |
DOTA-三(酸) - 酰氨基-DPEG(R)11-马来酰亚胺 |
146 |
zyl |
2024-11-22 |
| 92508 |
DOTA-Glu「cyclo(Arg-Gly-Asp-D-Phe-Lys)」2 |
150 |
kx |
2024-11-22 |
| 92509 |
CAS:834870-39-2 DOTA series |
151 |
zyl |
2024-11-22 |
| 92510 |
DOTA-cyclo(RGDfK)；DOTA-RGD |
145 |
wyh |
2024-11-22 |
| 92511 |
DOTA-PEG-SH、DOTA-PEG-Thiol的结构组成 |
143 |
kx |
2024-11-22 |
| 92512 |
DTPA-bis anhydride，二亚乙基三胺五乙酸二酐 |
173 |
wyh |
2024-11-22 |
| 92513 |
NOTA-PEG5000-Mal ；NOTA PEG5 马来酰亚胺 |
122 |
wyh |
2024-11-22 |
| 92514 |
DOTA-E「c(RGDfK)2」 |
130 |
kx |
2024-11-22 |
| 92515 |
DOTA-L-Lys(SA。Pam)-PSMA-617 DOTA偶联二膦酸盐和PSMA抑制剂 |
147 |
zcy |
2024-11-22 |
| 92516 |
DOTA-E[c(RGDfK)2]的应用领域 |
157 |
kx |
2024-11-22 |
| 92517 |
DOTA-氟喹诺酮衍生物 DOTA-fluoroquinolone derivatives |
138 |
zcy |
2024-11-22 |
| 92518 |
DOTA-NHS |
208 |
kx |
2024-11-22 |
| 92519 |
p-SCN-Bn-DTPA，102650-30-6，1-(4-异硫氰酸酯)二乙炔三胺 |
131 |
wyh |
2024-11-22 |
| 92520 |
NOTA-PEG-RGD |
135 |
kx |
2024-11-22 |
齐岳微信公众号
官方微信
库存查询